Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Recruiting

Phase 2

SAR444656Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Sponsor:

Sanofi

Code:

NCT06058156

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SAR444656 (KT-474)

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Sanofi on 2025-05-28.